Copyright
©The Author(s) 2023.
World J Gastroenterol. May 21, 2023; 29(19): 2950-2960
Published online May 21, 2023. doi: 10.3748/wjg.v29.i19.2950
Published online May 21, 2023. doi: 10.3748/wjg.v29.i19.2950
Table 3 Relationship between risk factors and outcomes of Helicobacter pylori eradication therapy, n (%)
Variable | Successful, n = 45 | Unsuccessful, n = 27 | P value |
Mean age in yr | 43.13 ± 12.19 | 39.22 ± 11.91 | 0.188 |
Male sex | 36 | 21 | 0.524 |
Smoking | 15 | 12 | 0.349 |
cagA | 21 (46.7) | 15 (55.6) | 0.313 |
s1 | 31 (68.9) | 11 (40.7) | 0.022 |
s2 | 15 (33.3) | 3 (11.1) | 0.031 |
m1 | 22 (48.9) | 5 (18.5) | 0.014 |
m2 | 21 (46.7) | 12 (44.4) | 0.525 |
AMX | 33 (73.3) | 26 (96.3) | 0.012 |
CIP | 18 (40.0) | 12 (44.4) | 0.45 |
TET | 15 (33.3) | 12 (44.4) | 0.244 |
CLR | 18 (40.0) | 20 (74.1) | 0.005 |
RIF | 27 (60.0) | 18 (40.0) | 0.379 |
- Citation: Asaad AM, El-Azab G, Abdelsameea E, Elbahr O, Kamal A, Abdel-Samiee M, Abdelfattah A, Abdallah H, Maher D, El-Refaie A, Ghanem SE, Ansari S, Awad SM. Susceptibility patterns and virulence genotypes of Helicobacter pylori affecting eradication therapy outcomes among Egyptian patients with gastroduodenal diseases. World J Gastroenterol 2023; 29(19): 2950-2960
- URL: https://www.wjgnet.com/1007-9327/full/v29/i19/2950.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i19.2950